Concentration-dependent effects of endogenous S-nitrosoglutathione on gene regulation by specificity proteins Sp3 and Sp1.

The activities of certain nuclear regulatory proteins are modified by high concentrations of S-nitrosothiols associated with nitrosative stress. In the present study, we have studied the effect of physiological (low microM) concentrations of the endogenous S-nitrosothiol, GSNO (S-nitrosoglutathione), on the activities of nuclear regulatory proteins Sp3 and Sp1 (specificity proteins 3 and 1). Low concentrations of GSNO increased Sp3 binding, as well as Sp3-dependent transcription of the cystic fibrosis transmembrane conductance regulatory gene, cftr. However, higher GSNO levels prevented Sp3 binding, augmented Sp1 binding and prevented both cftr transcription and CFTR (cystic fibrosis transmembrane conductance regulator) expression. We conclude that low concentrations of GSNO favour Sp3 binding to 'housekeeping' genes such as cftr, whereas nitrosative stress-associated GSNO concentrations shut off Sp3-dependent transcription, possibly to redirect cellular resources. Since low micromolar concentrations of GSNO also increase the maturation and activity of a clinically common CFTR mutant, whereas higher concentrations have the opposite effect, these observations may have implications for dosing of S-nitrosylating agents used in cystic fibrosis clinical trials.

[1]  R. Hales,et al.  Modulation of Sp1 and Sp3 in lung epithelial cells regulates ClC-2 chloride channel expression. , 2003, American journal of respiratory cell and molecular biology.

[2]  R. Neve,et al.  Sp1 and Sp3 Are Oxidative Stress-Inducible, Antideath Transcription Factors in Cortical Neurons , 2003, The Journal of Neuroscience.

[3]  B. Wiedenmann,et al.  Oxidative Stress Regulates Vascular Endothelial Growth Factor-A Gene Transcription through Sp1- and Sp3-dependent Activation of Two Proximal GC-rich Promoter Elements* , 2003, The Journal of Biological Chemistry.

[4]  B. Gaston,et al.  S-Nitrosoglutathione induces functional ΔF508-CFTR in airway epithelial cells , 2002 .

[5]  Hui Zhang,et al.  Cysteine String Protein Interacts with and Modulates the Maturation of the Cystic Fibrosis Transmembrane Conductance Regulator* , 2002, The Journal of Biological Chemistry.

[6]  M. Boyle,et al.  Evidence of CFTR function in cystic fibrosis after systemic administration of 4-phenylbutyrate. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  J. Stamler,et al.  Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis. , 2002, American journal of respiratory and critical care medicine.

[8]  J. Stamler,et al.  Basal and Stimulated Protein S-Nitrosylation in Multiple Cell Types and Tissues* , 2002, The Journal of Biological Chemistry.

[9]  Santiago Lamas,et al.  Nitrosylation The Prototypic Redox-Based Signaling Mechanism , 2001, Cell.

[10]  B. Gaston,et al.  S-Nitrosylation of mitochondrial caspases , 2001, The Journal of cell biology.

[11]  D. Gozal,et al.  S-Nitrosothiols signal the ventilatory response to hypoxia , 2001, Nature.

[12]  B. Pitt.  CFTR trafficking and signaling in respiratory epithelium. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[13]  B. Gaston,et al.  S-nitrosoglutathione increases cystic fibrosis transmembrane regulator maturation. , 2001, Biochemical and biophysical research communications.

[14]  M. Zeng,et al.  A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans , 2001, Nature.

[15]  R. Johns,et al.  Normoxic stabilization of hypoxia-inducible factor-1 expression and activity: redox-dependent effect of nitrogen oxides. , 2000, Molecular pharmacology.

[16]  G. Heda,et al.  Surface expression of the cystic fibrosis transmembrane conductance regulator mutant DeltaF508 is markedly upregulated by combination treatment with sodium butyrate and low temperature. , 2000, Biochemical and biophysical research communications.

[17]  B. Gaston,et al.  Decreased levels of nitrosothiols in the lower airways of patients with cystic fibrosis and normal pulmonary function. , 1999, The Journal of pediatrics.

[18]  G. Suske.  The Sp-family of transcription factors. , 1999, Gene.

[19]  F. Ratjen,et al.  Effect of inhaled nitric oxide on pulmonary function in cystic fibrosis. , 1999, Respiratory medicine.

[20]  H. Forman,et al.  Abnormal glutathione transport in cystic fibrosis airway epithelia. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[21]  S. Matalon,et al.  Nitric oxide inhibits heterologous CFTR expression in polarized epithelial cells. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[22]  J. Riordan.  Cystic fibrosis as a disease of misprocessing of the cystic fibrosis transmembrane conductance regulator glycoprotein. , 1999, American journal of human genetics.

[23]  E. Neufeld,et al.  Transcriptional Repression of the Cystic Fibrosis Transmembrane Conductance Regulator Gene, Mediated by CCAAT Displacement Protein/cut Homolog, Is Associated with Histone Deacetylation* , 1999, The Journal of Biological Chemistry.

[24]  W. Reenstra,et al.  Cystic fibrosis transmembrane conductance regulator activation by cAMP-independent mechanisms. , 1998, American journal of physiology. Cell physiology.

[25]  Simon C Watkins,et al.  Nitric oxide inhibits lipopolysaccharide-induced apoptosis in pulmonary artery endothelial cells. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[26]  M. Drumm,et al.  Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. , 1998, The Journal of clinical investigation.

[27]  L. Khachigian,et al.  Zinc Finger Transcription Factors Mediate High Constitutive Platelet-derived Growth Factor-B Expression in Smooth Muscle Cells Derived from Aortae of Newborn Rats* , 1998, The Journal of Biological Chemistry.

[28]  K. Do,et al.  S‐Nitrosoglutathione in Rat Cerebellum: Identification and Quantification by Liquid Chromatography‐Mass Spectrometry , 1997, Journal of neurochemistry.

[29]  Simon C Watkins,et al.  Nitric Oxide Protects Cultured Rat Hepatocytes from Tumor Necrosis Factor-α-induced Apoptosis by Inducing Heat Shock Protein 70 Expression* , 1997, The Journal of Biological Chemistry.

[30]  Alfred Hausladen,et al.  Nitrosative Stress: Activation of the Transcription Factor OxyR , 1996, Cell.

[31]  J. Stamler,et al.  S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control , 1996, Nature.

[32]  M. Beato,et al.  Functional Analyses of the Transcription Factor Sp4 Reveal Properties Distinct from Sp1 and Sp3 (*) , 1995, The Journal of Biological Chemistry.

[33]  F. W. Flitney,et al.  Chemical mechanisms underlying the vasodilator and platelet anti-aggregating properties of S-nitroso-N-acetyl-DL-penicillamine and S-nitrosoglutathione. , 1995, Bioorganic & medicinal chemistry.

[34]  R. Kopito,et al.  Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins. , 1994, The Journal of biological chemistry.

[35]  M. Beato,et al.  Sp1‐mediated transcriptional activation is repressed by Sp3. , 1994, The EMBO journal.

[36]  J. Stamler,et al.  Relaxation of human bronchial smooth muscle by S-nitrosothiols in vitro. , 1994, The Journal of pharmacology and experimental therapeutics.

[37]  J. Stamler,et al.  Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Matthew P. Anderson,et al.  Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive , 1992, Nature.

[39]  F. Collins,et al.  Cystic fibrosis: molecular biology and therapeutic implications. , 1992, Science.

[40]  L. Tsui,et al.  Characterization of the promoter region of the cystic fibrosis transmembrane conductance regulator gene. , 1991, The Journal of biological chemistry.

[41]  F. Collins,et al.  Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes. , 1991, Science.

[42]  R. Crystal,et al.  Expression of the cystic fibrosis transmembrane conductance regulator gene in cells of non-epithelial origin. , 1991, Nucleic acids research.

[43]  C. Winterbourn.  Oxidative reactions of hemoglobin. , 1990, Methods in enzymology.

[44]  R. Tjian,et al.  Analysis of Sp1 in vivo reveals mutiple transcriptional domains, including a novel glutamine-rich activation motif , 1988, Cell.